Purpose: Human papillomavirus (HPV) has been shown to disrupt late-stage implanting embryos. The objectives were (a) to assess the development of early embryos exposed to HPV DNA and (b) to analyze the blastocyst hatching process after HPV exposure.
Methods: The study involved exposing two-cell and 4–8-cell mouse embryos to DNA fragments from either HPV type 16, type 18 or DQA1 (control). The embryos were incubated for 120 h and assessed.
Results: HPV 16 and 18 inhibited two-cell embryo development. In contrast, delaying the exposure of HPV DNA until the 4–8-cell stage resulted in further embryonic development. There was 25.9% less blastocyst formed with HPV 16 exposure. Additionally, there were 25.9–31.8% more degenerated embryos with HPV 16 exposure.
Conclusions: The study demonstrated embryo stage-specific effects of HPV on early development. The results suggested HPV exposure was linked to two-cell embryo demise and delaying the exposure of HPV until later embryo stages permitted embryo development. HPV 16 was shown to decrease blastocyst formation while HPV 18 inhibited the blastocyst hatching process.
Similar content being viewed by others
REFERENCES
Graham DA, Herrington CS: The induction of chromosome abnormalities by human papillomaviruses. Papillomavirus 1998;9:1–5
Revzina NV, Diclemente RJ: Prevalence and incidence of human papillomavirus infection in women in the USA: A systematic review. Int J STD AIDS 2005;16:528–537
Fujita M, Inoue M, Tanizawa O, Iwamoto S, Enomoto T: Alterations of the p53 gene in human primary cervical carcinoma with and without human papillomavirus infection. Cancer Res 1992;52:5323–5328
Hermonat PL, Kechelava S, Lowery CL, Korourian S: Trophoblasts are the preferential target for human papilloma virus infection in spontaneously aborted products of conception. Hum Pathol 1998;29:170–174
Hermonat PL, Han L, Wendel PJ, Quirk JG, Stern S, Lowery CL, Rechtin TM: Human papillomavirus is more prevalent in first trimester spontaneously aborted products of conception compared to elective specimens. Virus Gen 1997;14:13–17
Manavi M, Czerwenka KF, Schurz B, Knogler W, Kubista E, Reinold E: Latent cervical virus infection as a possible cause of early abortion. Gynakol Geburtshilfliche Rundsch 1992;32:84–87
Malhomme O, Dutheil N, Rabreau M, Armbruster-Moraes E, Schlehofer JR, Dupressoir T: Human genital tissues containing DNA of adeno-associated virus lack DNA sequences of the helper viruses, adenovirus, herpes simplex virus or cytomegalovirus but frequently contain human papillomavirus DNA. J Gen Virol 1997;78:1957–1962
Sifakis S, Ergazaki M, Sourvinos G, Koffa M, Koumantakis E, Spandidos DA: Evaluation of parvo B19, CMV, and HPV viruses in human aborted material using polymerase chain reaction technique. Eur J Obstet Gynecol Reprod Biol 1998;76:169–173
Stagno S, Pass RF, Dworsky ME, Handerson RE, Moore EG, Walton PD, Alford CA. Congenital cytomegalovirus infection: The relative importance of primary and recurrent maternal infection. N Engl J Med 1982;306:945–949
Icart J, Didier J, Dalens M, Chabanon G, Boucays A: Prospective study of EBV infection during pregnancy. Biomedicine 1981;34:160–163
Brown ZA, Vontver LA, Benedetti J, Critchlow CW, Sells CJ, Berry S, Corey L: Effects on infants of a first episode of genital herpes during pregnancy. N Engl J Med 1987;317:1246–1251
Monif GR: Maternal mumps infections during gestation: Observations in the progeny. Am J Obstet Gynecol 1974;119:549–551
Miller E, Cradock-Watson JE, Pollock TM: Consequences of confirmed maternal rubella at successive stages of pregnancy. Lancet 1982;2:781–784
Alani RM, Münger K: Human papillomaviruses and associated malignancies. J Clin Oncol 1997;16:330–337
Saiki RK, Walsh PS, Levenson CH, Erlich HA: Genetic analysis of amplified DNA with immobilized sequence-specific oligonucleotide probes. Proc Natl Acad Sci USA 1989;86:6230–6234
Erlich HA, Bugawan TL: HLA class II gene polymorphism: DNA typing, evolution, and relationship to disease susceptibility. In PCR Technology: Principles and Applications for DNA Amplifications, Erlich HA (ed.), New York, Stockton Press, 1989; pp. 193–208,
Ting Y, Manos MM: Detection and typing of genital human papillomaviruses. In PCR Protocols, Innis MA, Gelfand DH, Sninsky JJ, White TJ (eds.), New York, Academic Press, 1990; pp. 356–367
Sarkar FH, Crissman JD: Detection of human papilloma virus DNA sequences by polymerase chain reaction. Biotechniques 1990;9:180–185
Chan PJ, Kalugdan TH, Cabrera M, Seraj IM, King A: Detection of exogenous DNA in blastocysts after continuous exposure to DNA carrier sperm. J Assist Reprod Genetics 1996;13:602–605
Rowland SC, Jacobson JD, Patton WC, King A, Chan PJ: Dual fluorescence analysis of DNA apoptosis in sperm. Am J Obstet Gynecol 2003;188:1156–1157
Calinisan JH, Chan SR, King A, Chan PJ: Human papillomavirus and blastocyst apoptosis. J Assist Reprod Genet 2002;19:132–136
Scheffner M, Huibregtse JM, Vierstra RD, Howley PM: The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53. Cell 1993;75:495–505
Hengstermann A, Linares LK, Ciechanover A, Whitaker NJ, Scheffner M: Complete switch from Mdm2 to human papillomavirus E6-mediated degradation of p53 in cervical cancer cells. Proc Natl Acad Sci USA 2001;98:1218–1223
Graham DA, Herrington CS: The induction of chromosome abnormalities by human papillomaviruses. Papillomavirus Rep 1998;9:1–5
Dyson N, Howley PM, Munger K, Harlow E: The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science 1989;243:934–937
Massimi P, Pim D, Banks L: Human papillomavirus type 16 E7 binds to the conserved carboxy-terminal region of the TATA box protein and this contributes to E& transforming activity. J Gen Virol 1997;78:2607–2613
Dürst M, Croce CM, Gissmann L, Schwarz E, Huebner K: Papillomavirus sequences integrate near cellular oncogenes in some cervical carcinomas. Proc Natl Acad Sci USA 1987;84:1070–1074
Yunis JJ, Soreng AL, Bowe AE: Fragile sites are targets of diverse mutagens and carcinogens. Oncogene 1987;1:59–69
Cannizzaro LA, Dürst M, Mendez MJ, Hecht BK, Hecht F: Regional chromosome localization of human papillomavirus integration sites near fragile sites, oncogenes and cancer chromosome breakpoints. Cancer Genet Cytogenet 1988;33:93–98
Popescu NC, DiPaolo JA: Preferential sites for viral integration on mammalian genome. Cancer Genet Cytogenet 1989;42:157–71
Rassool FV, McKeithan TW, Neilly ME, van Melle E, Espinosa R-III, Le Beau MM: Preferential integration of marker DNA into the chromosomal fragile site at 3p14: An approach to cloning fragile sites. Proc Natl Acad Sci USA 1991;88:6657–6661
Smith PP, Friedman CL, Bryant EM, McDougall JK: Viral integration and fragile sites in human papillomavirus-immortalized human keratinocyte cell lines. Genes, Chromosom Cancer 1995;5:150–157
Kessis TD, Connolly DC, Hedrick L, Cho KR: Expression of HPV 16 E6 or E7 increases integration of foreign DNA. Oncogene 1996;13:427–431
Ferber MJ, Eilers P, Schuuring E, Fenton JAL, Fleuren GJ, Kenter G, Szuhai K, Smith DI, Raap AK, Brink AATP: Positioning of cervical carcinoma and Burkitt lymphoma translocationn breakpoints with respec to the human papillomavirus integration cluster in FRA8C at 8q24.13. Cancer Genet Cytogenet 2004;154:1–9
Gallego MI, Lazo PA: Deletion in human chromosome region 12q13–15 by integration of human papillomvirus DNA in a cervical carcinoma cell line. J Biol Chem 1995;270:24321–24326
Tanaka H, Karube A, Kodama H, Fukuda J, Tanaka T: Mass screening for human papillomavirus type 16 infection in infertile couples. J Reprod Med 2000;45:907–911
Strehler E, Sterzik K, Malthaner D, Hoyer H, Nindl I, Schneider A: Influence of ovarian stimulation on the detection of human papillomavirus DNA in cervical scrapes obtained from patients undergoing assisted reproductive techniques. Fertil Steril 1999;71:815–820
Repper CF, Carranza-Lira S, Alcivia GJC, Gaona AR, Garcia LA: Modified factors in the study of the infertile couple in women with papillomavirus cervical infection, descriptive analysis. Ginecol Obstet Mex 1995;63:502–504
Schiff M, Miller J, Masuk M, van Asselt King L, Altobelli KK, Wheeler CM, Becker TM: Contraceptive and reproductive risk factors for cervical intraepithelial neoplasia in American Indian women. Int J Epidemiol. 2000;29:983–990
Lundqvist M, Westin C, Lundkvist O, Simberg N, Strand A, Andersson S, Wilander E: Cytologic screening and human papilloma virus test in women undergoing artificial fertilization. Acta Obstet Gynecol Scand 2002;81:949– 953
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Henneberg, A.A., Patton, W.C., Jacobson, J.D. et al. Human papilloma virus DNA exposure and embryo survival is stage-specific. J Assist Reprod Genet 23, 255–259 (2006). https://doi.org/10.1007/s10815-006-9030-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10815-006-9030-8